QHSLabSTU:E1Z 50 EV-to-FCF is 133.88 as of Jul. 08, 2026. GuruFocus rates STU:E1Z with a GF Score™ of 50/100 and a GF Value™ of €0.16. The stock has 3 warning signs investors should review. Among 416 Medical Devices & Instruments companies, QHSLab ranks worse than 88.94% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, QHSLab's Enterprise Value is €3.21 Mil.
QHSLab's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was €0.02 Mil. Therefore, QHSLab's EV-to-FCF for today is 133.88.
The historical rank and industry rank for QHSLab's EV-to-FCF or its related term are showing as below:
STU:E1Z'
s EV-to-FCF Range Over the Past 10 Years
Min: -134.01 Med: -8.41 Max: 380.27
Current: 130.68
During the past 13 years, the highest EV-to-FCF of QHSLab was 380.27. The lowest was -134.01. And the median was -8.41.
STU:E1Z's EV-to-FCF is ranked worse than 88.94% of 416
companies
in the Medical Devices & Instruments industry
Industry Median: 23.515
vs STU:E1Z: 130.68
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
As of today (2026-07-08), QHSLab's stock price is €0.224.
QHSLab's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was €0.032. Therefore, QHSLab's PE Ratio (TTM) for today is 7.00.
QHSLab (STU:E1Z) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
QHSLab's share price for today is €0.224.
QHSLab's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.032.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
QHSLab EV-to-FCF Related Terms
QHSLab EV-to-FCF Historical Data
* Premium members only.
The historical data trend for QHSLab's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, QHSLab's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
QHSLab EV-to-FCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, QHSLab's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where QHSLab's EV-to-FCF falls into.
QHSLab's current Enterprise Value is €3.21 Mil.
QHSLab's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.02 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
QHSLab (STU:E1Z) has a EV-to-FCF of 133.88 as of Jul. 08, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on QHSLab and its competitors. According to the industry distribution chart, QHSLab ranks #370 out of 416 companies in the Medical Devices & Instruments industry, placing it in the top 88.9%.
Is QHSLab's EV-to-FCF too high?
QHSLab's current EV-to-FCF is 133.88. The Medical Devices & Instruments industry median EV-to-FCF is 23.52. QHSLab's value of 133.88 is 469.3% above this industry median. Based on the distribution chart, QHSLab ranks #370 out of 416 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, QHSLab has a GF Score™ of 50/100, reflecting its overall financial health beyond just this single metric.
How does QHSLab's EV-to-FCF compare to ADMT and RMSL?
According to the Medical Devices & Instruments industry distribution chart, QHSLab ranks #370 out of 416 companies for EV-to-FCF. This places QHSLab in the lower half of its industry. The industry median EV-to-FCF is 23.52. QHSLab's value of 133.88 is 469.3% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Devices & Instruments company?
The median EV-to-FCF among Medical Devices & Instruments companies is 23.52, based on 416 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. QHSLab's current EV-to-FCF of 133.88 is 469.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on QHSLab and its competitors. For the Medical Devices & Instruments industry, the median EV-to-FCF is 23.52 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. QHSLab's current EV-to-FCF is 133.88. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is QHSLab stock overvalued right now?
QHSLab (STU:E1Z) has a current EV-to-FCF of 133.88. The stock's GF Value™ is €0.16, compared to a current price of €0.22 — trading 40% above its estimated fair value. The current EV-to-FCF is 133.88 and 469.3% above the Medical Devices & Instruments industry median of 23.52. QHSLab's overall GF Score™ is 50/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For QHSLab (STU:E1Z), the current EV-to-FCF is 133.88 as of Jul. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is QHSLab (STU:E1Z) Overvalued in 2026?
Based on GuruFocus' analysis, QHSLab stock appears to be overvalued.
The current stock price of €0.22 is trading 40% above its estimated GF Value™ of €0.16.
Key valuation signals for STU:E1Z:
EV-to-FCF: 133.88
GF Value™: €0.16 vs. price of €0.22 (40% above fair value)
Industry Position: 469.3% above the Medical Devices & Instruments median (#370 of 416)
No single metric tells the full story. See the STU:E1Z stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
QHSLab Inc is a medical device company providing digital healthcare solutions and point-of-care-diagnostic tests to primary care physicians. The company is a medical device technology and software as a service (SaaS) company focused on enabling primary care physicians (PCPs) to increase their revenues by providing them with relevant, value-based tools to evaluate and treat chronic disease as well as provide preventive care through reimbursable procedures.
50GF Score
Get the complete analysis for STU:E1Z
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:E1Z has been successfully added to your 
